Fairmount Healthcare Fund II GP LLC
Director, 10% Owner · Viridian Therapeutics, Inc.\DE
Every open-market stock purchase Fairmount Healthcare Fund II GP LLC has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where how the prices paid compare to where the stock trades now.
Where the buys stand today
- VRDN−13.7% vs price paidViridian Therapeutics, Inc.\DE
One purchase totalling $10.0M at an average of $22.00 per share; the stock last traded at $18.99. See all insider buying in VRDN →
Avg price paid$22.00Latest price$18.99Market cap$2.1B
All reported buys
Follow new qualifying clusters involving Fairmount Healthcare Fund II GP LLC or other insiders
Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.
About this data
Figures are parsed from Fairmount Healthcare Fund II GP LLC's Form 4 filings on SEC EDGAR (CIK 1830382) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.